Comparison of Low-, Moderate-, and High-Molecular-Weight Hyaluronic Acid Injections in Delaying Time to Knee Surgery

Overview

Journal J Arthroplasty

Specialty Orthopedics

Date 2017 Jun 14

PMID 28606459

Citations 13

Authors

Anand R Shewale

Charles L Barnes

Lori A Fischbach

Songthip T Ounpraseuth

Jacob T Painter

Bradley C Martin

Affiliations

Soon will be listed here.

Abstract

Background: We compared the effectiveness of low-molecular-weight (MW) hyaluronic acid (HA) injections (LMWHA), moderate-MW HA injections (MMWHA), and high-MW HA injections (HMWHA) for prevention or delay of knee surgery in patients with knee osteoarthritis.

Methods: An observational cohort study using LifeLink Plus claims (2006-2015) was used. The primary outcome measure of the study included all surgical interventions of the knee. The secondary outcome measures were the following: (1) unicompartmental knee arthroplasty or total knee arthroplasty and (2) total knee arthroplasty only. A high-dimensional propensity score (hdPS) using 1:1 matching was used to adjust for confounding. The likelihood of each outcome was assessed using Cox proportional hazard models.

Results: A cohort of 30,417 incident HA users with knee osteoarthritis met our inclusion-exclusion criteria. There was no difference in the likelihood of composite surgical events between LMWHA users (hazard ratio, 0.939; 95% confidence interval, 0.870-1.013) and MMWHA users (hazard ratio, 1.032; 95% confidence interval, 0.952-1.119) when compared with HMWHA users in a matched hdPS analysis. However, a significantly lower likelihood for all outcome measures was demonstrated in LMWHA and MMWHA users compared with HMWHA users when hdPS was not used.

Conclusion: There was no significant difference in the likelihood of surgical interventions between LMWHA, MMWHA, and HMWHA users after accounting for empirically derived confounders.

Citing Articles

Effects of Hyaluronic Acid (HA) and Platelet-Rich Plasma (PRP) on Mandibular Mobility in Temporomandibular Joint Disorders: A Controlled Clinical Trial.

Checinski M, Chlubek D, Sikora M Biomolecules. 2024; 14(10).

PMID: 39456149 PMC: 11505905. DOI: 10.3390/biom14101216.

Hyaluronic Acid/Platelet-Rich Plasma Mixture Improves Temporomandibular Joint Biomechanics: A Systematic Review.

Checinski M, Lubecka K, Blizniak F, Chlubek D, Sikora M Int J Mol Sci. 2024; 25(17).

PMID: 39273351 PMC: 11395054. DOI: 10.3390/ijms25179401.

A randomized controlled trial for comparing efficacy and safety between intraarticular polynucleotide and hyaluronic acid for knee osteoarthritis treatment.

Kim T, Chang M, Shin C, Chang C, Kang S Sci Rep. 2023; 13(1):9419.

PMID: 37296122 PMC: 10256705. DOI: 10.1038/s41598-023-35982-z.

Propensity Scores: Confounder Adjustment When Comparing Nonrandomized Groups in Orthopaedic Surgery.

Larson D, Zaniletti I, Lewallen D, Berry D, Kremers H J Arthroplasty. 2023; 38(4):622-626.

PMID: 36639115 PMC: 10023476. DOI: 10.1016/j.arth.2022.08.030.

Impact of Kefiran Exopolysaccharide Extraction on Its Applicability for Tissue Engineering and Regenerative Medicine.

Correia S, Goncalves C, Oliveira J, Radhouani H, Reis R Pharmaceutics. 2022; 14(8).

PMID: 36015340 PMC: 9415419. DOI: 10.3390/pharmaceutics14081713.

References

Wobig M, Bach G, Beks P, Dickhut A, Runzheimer J, Schwieger G . The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther. 1999; 21(9):1549-62. DOI: 10.1016/s0149-2918(00)80010-7. View

Moreland L . Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther. 2003; 5(2):54-67. PMC: 165033. DOI: 10.1186/ar623. View

Karatosun V, Unver B, Gocen Z, Sen A . Comparison of two hyaluronan drugs in patients with advanced osteoarthritis of the knee. A prospective, randomized, double-blind study with long term follow-up. Clin Exp Rheumatol. 2005; 23(2):213-8. View

Lee P, Kim Y, Lim Y, Lee C, Sim W, Ha C . Comparison between high and low molecular weight hyaluronates in knee osteoarthritis patients: open-label, randomized, multicentre clinical trial. J Int Med Res. 2006; 34(1):77-87. DOI: 10.1177/147323000603400110. View

Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G . Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006; (2):CD005321. PMC: 8884110. DOI: 10.1002/14651858.CD005321.pub2. View

Desmeules F, Dionne C, Belzile E, Bourbonnais R, Fremont P . Waiting for total knee replacement surgery: factors associated with pain, stiffness, function and quality of life. BMC Musculoskelet Disord. 2009; 10:52. PMC: 2694153. DOI: 10.1186/1471-2474-10-52. View

Schneeweiss S, Rassen J, Glynn R, Avorn J, Mogun H, Brookhart M . High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009; 20(4):512-22. PMC: 3077219. DOI: 10.1097/EDE.0b013e3181a663cc. View

Bannuru R, Natov N, Obadan I, Price L, Schmid C, McAlindon T . Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum. 2009; 61(12):1704-11. DOI: 10.1002/art.24925. View

Greenwald R . Oxygen radicals, inflammation, and arthritis: pathophysiological considerations and implications for treatment. Semin Arthritis Rheum. 1991; 20(4):219-40. DOI: 10.1016/0049-0172(91)90018-u. View

10.

Johanson N, Kleinbart F, Cerynik D, Brey J, Ong K, Kurtz S . Temporal relationship between knee arthroscopy and arthroplasty: a quality measure for joint care?. J Arthroplasty. 2010; 26(2):187-91. DOI: 10.1016/j.arth.2010.03.001. View

11.

Verduijn M, Grootendorst D, Dekker F, Jager K, le Cessie S . The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method. Nephrol Dial Transplant. 2010; 26(1):56-61. DOI: 10.1093/ndt/gfq661. View

12.

Berger A, Bozic K, Stacey B, Edelsberg J, Sadosky A, Oster G . Patterns of pharmacotherapy and health care utilization and costs prior to total hip or total knee replacement in patients with osteoarthritis. Arthritis Rheum. 2011; 63(8):2268-75. DOI: 10.1002/art.30417. View

13.

Austin P . An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behav Res. 2011; 46(3):399-424. PMC: 3144483. DOI: 10.1080/00273171.2011.568786. View

14.

Axe J, Snyder-Mackler L, Axe M . The role of viscosupplementation. Sports Med Arthrosc Rev. 2013; 21(1):18-22. DOI: 10.1097/JSA.0b013e3182673241. View

15.

Litwic A, Edwards M, Dennison E, Cooper C . Epidemiology and burden of osteoarthritis. Br Med Bull. 2013; 105:185-99. PMC: 3690438. DOI: 10.1093/bmb/lds038. View

16.

Noordzij M, Leffondre K, van Stralen K, Zoccali C, Dekker F, Jager K . When do we need competing risks methods for survival analysis in nephrology?. Nephrol Dial Transplant. 2013; 28(11):2670-7. DOI: 10.1093/ndt/gft355. View

17.

Reid M . Viscosupplementation for osteoarthritis: a primer for primary care physicians. Adv Ther. 2013; 30(11):967-86. PMC: 4351751. DOI: 10.1007/s12325-013-0068-6. View

18.

Ayhan E, Kesmezacar H, Akgun I . Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014; 5(3):351-61. PMC: 4095029. DOI: 10.5312/wjo.v5.i3.351. View

19.

Singh J, Lewallen D . Are outcomes after total knee arthroplasty worsening over time? A time-trends study of activity limitation and pain outcomes. BMC Musculoskelet Disord. 2014; 15:440. PMC: 4301928. DOI: 10.1186/1471-2474-15-440. View

20.

Koenig K, Ong K, Lau E, Vail T, Berry D, Rubash H . The Use of Hyaluronic Acid and Corticosteroid Injections Among Medicare Patients With Knee Osteoarthritis. J Arthroplasty. 2015; 31(2):351-5. DOI: 10.1016/j.arth.2015.08.024. View